Co-funded by the Erasmus+ Programme of the European Union
The discovered antibiotics have started failing. The infections caused by drug-resistant bacteria are one of the world’s most urgent public health issue. The adverse impact of resistance seen in gram-negative bacteria (GNB) is no different. The bacteria are increasingly resistant to most available antibiotics, one such broad-spectrum group of antibiotics…
The Global Action Plan is one of the key initiatives by the World Health Organization (WHO) to combat the increasing incidence of antimicrobial resistance (AMR). In this direction, WHO has articulated a list of pathogens under the umbrella of ‘priority pathogens’ to provide strategic direction to research and develop new…
Antibiotics are the entities that help us to fight against the bacterial infections. These antibiotics are being used as therapeutic agents in humans while as therapeutic, prophylactic as well as growth promoters in case of animals. The release of antibiotics in human and animal waste results in the entry of…
Antibiotic resistance (ABR) is ‘one health’ challenge and it needs to be tackled with the one health approach. The injudicious use of antibiotics in human, animal and plant health has increased the abundance of antibiotic, antibiotic-resistant bacteria (ARBs) and antibiotic-resistant genes (ARGs) in the environment. It has been found that…
Project reference: 598515-EPP-1-2018-1-IN-EPPKA2-CBHE-JP